These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14748545)

  • 1. Aldose reductase: a key player in myocardial ischemic injury.
    Kaneko M; Ramasamy R
    Exerc Sport Sci Rev; 2004 Jan; 32(1):19-23. PubMed ID: 14748545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central role for aldose reductase pathway in myocardial ischemic injury.
    Hwang YC; Kaneko M; Bakr S; Liao H; Lu Y; Lewis ER; Yan S; Ii S; Itakura M; Rui L; Skopicki H; Homma S; Schmidt AM; Oates PJ; Szabolcs M; Ramasamy R
    FASEB J; 2004 Aug; 18(11):1192-9. PubMed ID: 15284219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase: a novel target for cardioprotective interventions.
    Ramasamy R
    Curr Drug Targets; 2003 Nov; 4(8):625-32. PubMed ID: 14577653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
    Ramasamy R; Oates PJ; Schaefer S
    Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.
    Hwang YC; Shaw S; Kaneko M; Redd H; Marrero MB; Ramasamy R
    FASEB J; 2005 May; 19(7):795-7. PubMed ID: 15746188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase activation is a key component of myocardial response to ischemia.
    Hwang YC; Sato S; Tsai JY; Yan S; Bakr S; Zhang H; Oates PJ; Ramasamy R
    FASEB J; 2002 Feb; 16(2):243-5. PubMed ID: 11772943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury.
    Kaneko M; Bucciarelli L; Hwang YC; Lee L; Yan SF; Schmidt AM; Ramasamy R
    Ann N Y Acad Sci; 2005 Jun; 1043():702-9. PubMed ID: 16037296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase pathway contributes to vulnerability of aging myocardium to ischemic injury.
    Ananthakrishnan R; Li Q; Gomes T; Schmidt AM; Ramasamy R
    Exp Gerontol; 2011 Sep; 46(9):762-7. PubMed ID: 21600277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibition: emerging drug target for the treatment of cardiovascular complications.
    Reddy AB; Ramana KV
    Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):25-32. PubMed ID: 19886861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase inhibitors improve myocardial reperfusion injury in mice by a dual mechanism.
    Iwata K; Matsuno K; Nishinaka T; Persson C; Yabe-Nishimura C
    J Pharmacol Sci; 2006 Sep; 102(1):37-46. PubMed ID: 16936455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic postconditioning during reperfusion attenuates oxidative stress and intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion via aldose reductase.
    Wen SH; Ling YH; Li Y; Li C; Liu JX; Li YS; Yao X; Xia ZQ; Liu KX
    Surgery; 2013 Apr; 153(4):555-64. PubMed ID: 23218881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M; Muthenna P; Suryanarayana P; Petrash JM; Reddy GB
    Asia Pac J Clin Nutr; 2008; 17(4):558-65. PubMed ID: 19114390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors.
    Balestri F; Quattrini L; Coviello V; Sartini S; Da Settimo F; Cappiello M; Moschini R; Del Corso A; Mura U; La Motta C
    Cell Chem Biol; 2018 Nov; 25(11):1414-1418.e3. PubMed ID: 30122369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: possible role for aldose-reductase inhibition.
    Gottmann U; Brinkkoetter PT; Hoeger S; Gutermann K; Coutinho ZM; Ruf T; Hui S; Liu Z; Schnuelle P; van der Woude FJ; Braun C; Yard BA
    Transplantation; 2007 Sep; 84(6):755-62. PubMed ID: 17893609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion.
    Ramasamy R; Trueblood N; Schaefer S
    Am J Physiol; 1998 Jul; 275(1):H195-203. PubMed ID: 9688914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
    Bhadada SV; Vyas VK; Goyal RK
    Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat.
    Ramasamy R; Liu H; Oates PJ; Schaefer S
    Cardiovasc Res; 1999 Apr; 42(1):130-9. PubMed ID: 10435004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase / polyol inhibitors for diabetic retinopathy.
    Obrosova IG; Kador PF
    Curr Pharm Biotechnol; 2011 Mar; 12(3):373-85. PubMed ID: 20939801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discoveries in research on diabetic keratopathy.
    Cisarik-Fredenburg P
    Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium.
    Hwang YC; Bakr S; Ellery CA; Oates PJ; Ramasamy R
    FASEB J; 2003 Dec; 17(15):2331-3. PubMed ID: 14525943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.